10 June 2026
10 June 2026
Novo Nordisk’s Ibrahim Kamstrup-Akkaoui outlines how the Danish GLP-1 giant is embedding AI into its clinical foundation.
If ACD680 were to reach the market, it would deepen Lilly’s Alzheimer’s legacy past anti-amyloid-beta therapy, Kisunla.
The Middle East conflict has accentuated long-standing vulnerabilities in the pharma manufacturing supply chain.
A spokesperson for the Chinese company said “we will take immediate action” following the military designation.
The new MHRA sandbox will allow innovators to test AI systems to enhance medicines’ safety and predict side effects.
Ignite will separate from Aditxt and is expected to become an independent public company called Ignite Proteomics.
Real-world data presented at ADA 2026 showcased the impact of Sanofi's teplizumab in slowing type 1 diabetes (T1D) progression.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
